Cardiovascular risk factors in women with previous gestational diabetes mellitus: a systematic review and meta-analysis

Simple item page
dc.contributor.authorPathirana, M.M.
dc.contributor.authorLassi, Z.
dc.contributor.authorAli, A.
dc.contributor.authorArstall, M.
dc.contributor.authorRoberts, C.T.
dc.contributor.authorAndraweera, P.H.
dc.date.issued2021
dc.descriptionPublished online: 27 October 2020
dc.description.abstractThis systematic review and meta-analysis aimed to synthesize evidence on conventional cardiovascular disease (CVD) risk factors among women with previous Gestational Diabetes Mellitus (GDM). The review protocol is registered with PROSPERO (CRD42019118149). PubMed, CINAHL, SCOPUS, and EMBASE databases were searched. Studies reporting on CVD risk factors in women with previous GDM compared to women without previous GDM were selected. A total of 139 studies were eligible, of which 93 were included in the meta-analysis. Women with previous GDM have significantly higher systolic blood pressure (2.47 mmHg 95% CI 1.74 to 3.40, n = 48, 50,118 participants) diastolic blood pressure (1.89 mmHg 95% CI 1.32 to 2.46, n = 48, 49,495 participants), BMI (1.54 kg/m2 95% CI 1.32 to 2.46, n = 78, 255,308 participants), total cholesterol (0.26 SMD 95% CI 0.15 to 0.37, n = 48, 38,561 participants), LDL cholesterol (0.19 SMD 95% CI 0.08 to 0.30, n = 44, 16,980 participants), triglycerides (0.56 SMD 95% CI 0.42 to 0.70, n = 46, 13,175 participants), glucose (0.69 SMD 95% CI 0.56 to 0.81, n = 55, 127,900 participants), insulin (0.41 SMD 95% CI 0.23 to 0.59, n = 32, 8881 participants) and significantly lower HDL cholesterol (-0.28 SMD 95% CI -0.39 to -0.16, n = 56, 35,882 participants), compared to women without previous GDM. The increased blood pressure, total cholesterol, triglycerides and glucose are seen as early as <1 year post-partum.Women with previous GDM have a higher risk of CVD based on significant increases in conventional risk factors. Some risk factors are seen as early as <1 year post-partum. Women with GDM may benefit from early screening to identify modifiable CVD risk factors.
dc.description.statementofresponsibilityMaleesa M. Pathirana, Zohra Lassi, Anna Ali, Margaret Arstall, Claire T. Roberts, Prabha H. Andraweera
dc.identifier.citationReviews in Endocrine and Metabolic Disorders, 2021; 22(4):729-761
dc.identifier.doi10.1007/s11154-020-09587-0
dc.identifier.issn1389-9155
dc.identifier.issn1573-2606
dc.identifier.orcidPathirana, M.M. [0000-0002-5817-4156]
dc.identifier.orcidLassi, Z. [0000-0002-5350-6334]
dc.identifier.orcidAli, A. [0000-0002-7832-1694]
dc.identifier.orcidArstall, M. [0000-0003-0760-6382]
dc.identifier.orcidRoberts, C.T. [0000-0002-9250-2192]
dc.identifier.orcidAndraweera, P.H. [0000-0003-2434-8370]
dc.identifier.urihttp://hdl.handle.net/2440/130188
dc.language.isoen
dc.publisherSpringer
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1141382
dc.rights© Springer Science+Business Media, LLC, part of Springer Nature 2020
dc.source.urihttps://doi.org/10.1007/s11154-020-09587-0
dc.subjectCardiovascular disease
dc.subjectCardiovascular risk factors
dc.subjectGestational diabetes
dc.subjectWomen’s health
dc.titleCardiovascular risk factors in women with previous gestational diabetes mellitus: a systematic review and meta-analysis
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications